• 1
    Hemminki K, Riihimaki M, Sundquist K, et al. Site-specific survival rates for cancer of unknown primary (CUP) according to location of metastases. Int J Cancer, in press; doi: 10.1002/ijc.27988.
  • 2
    National Collaborating Centre for Cancer. Diagnosis and management of metastatic malignant disease of unknown primary origin. National Institute for Health and Clinical Excellence (NICE UK) clinical guidelines CG104. Cardiff: National Collaborating Centre for Cancer, 2010. 1 p. Available at: (accessed December 24, 2012).
  • 3
    Briasoulis E, Pavlidis N. Cancer of unknown primary origin. Oncologist 1997;2:142152.
  • 4
    Abbruzzese JL, Abbruzzese MC, Hess KR, et al. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 1994;12:12721280.
  • 5
    Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003;39:19902005.
  • 6
    Johansson LA, Westerling R. Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. Int J Epidemiol 2000;29:495502.
  • 7
    World Health Organization. International statistical classification of diseases and related health problems, 10th Revision, vol. 2. Instruction manual. Geneva: WHO, 2010. 31. Available at: (accessed December 29, 2012).
  • 8
    Pentheroudakis G, Goflinopoulos V, Pavlidis N. Switching benchmarks in cancer of unknown primary: from autopsy to microarray. Eur J Cancer 2007;43:2026203.
  • 9
    Greco FA, Oien K, Erlander M, et al. Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes. Ann Oncol 2012;23:298304.